DIGIFAB

This brand name is authorized in United States. It is also authorized in Canada, Malta, UK.

Active ingredients

The drug DIGIFAB contains one active pharmaceutical ingredient (API):

1
UNII YB12NQZ1YN - OVINE DIGOXIN IMMUNE FAB
 
Read more about Digoxin antibodies

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB24 Digitalis antitoxin V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02361043
GB Medicines & Healthcare Products Regulatory Agency 204779
MT Medicines Authority AA565/66701
US FDA, National Drug Code 50633-120

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈